Contrast enhanced ultrasound of the liver - State of the art;Kontrastverstärkte ultraschalluntersuchung der leber - Aktueller wissensstand

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 22, 2007, Pages 1225-1231

  Dietrich, Christoph F ^a   Schreiber Dietrich, D ^a   Schuessler, G ^a   Ignee, A ^a  

^a CARITAS KRANKENHAUS   (Germany)

Author keywords

Contrast enhanced sonography; Focal nodular hyperplasia; Hepatocellular adenoma; Hepatocellular carcinoma; Liver metastases; Liver sonography; Local ablative therapy; SonoVue

Indexed keywords

ECHO CONTRAST MEDIUM; SHU 508; SONOVUE; CONTRAST MEDIUM;

ADOLESCENT; ADULT; AGED; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER METASTASIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; REVIEW; SCHOOL CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; LIVER; LIVER TUMOR; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34347268438     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979403     Document Type: Review

References (50)

1. Albrecht T, Blomley M, Bolondi L et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004; 25: 249-256
2. Albrecht T, Blomley MJ, Burns PN et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227:361-370
3. Bartolotta TV, Midiri M, Quaia E et al. Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 2005; 15: 1643-1649
4. Bauditz J, Rudolph B, Wermke W. Osteoclast-like giant cell tumors of the pancreas and liver. World J Gastroenterol 2006; 12: 7878-7883
5. Bernatik T, Becker D, Neureiter D et al. Detection of liver metastases - comparison of contrast - enhanced ultrasound using first versus second generation contrast agents. Ultraschall Med 2003; 24: 175-179
6. Bernatik T, Strobel D, Hahn EG, Becker D. Detection of liver metastases: comparison of contrast-enhanced wide-band harmonic imaging with conventional ultrasonography. J Ultrasound Med 2001; 20: 509-515
7. Bleuzen A, Huang C, Olar M, Tchuenbou J, Tranquart F. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing. Ultraschall Med 2006; 27: 40-48
8. Blomley M, Albrecht T, Cosgrove D et al. Stimulated acoustic emission imaging ("sono-scintigraphy") with the ultrasound contrast agent Levovist: a reproducible Doppler ultrasound effect with potential clinical utility. Acad Radiol 1998; 5 (Suppl 1): S236-S239
9. Blomley MJ et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999; 210: 409-416
10. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003; 39: 1076-1084
11. Bolondi L, Gaiani S, Celli N et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005; 42: 27-34
12. Dettmer A, Kirchhoff TD, Gebel M et al. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma. World J Gastroenterol 2006; 12: 3707-3715
13. Dietrich CF. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol 2004; 51 (Suppl): S9-17
14. Dietrich CF, Chichakli M, Hirche TO et al. Sonographic findings of the hepatobiliary-pancreatic system in adult patients with cystic fibrosis. J Ultrasound Med 2002; 21: 409-416
15. Dietrich CF, Ignee A et al. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004; 53: 401-405
16. Dietrich CF, Kratzer W et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699-1705
17. Dietrich CF, Lee JH, Herrmann G et al. Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 1997; 26: 467-472
18. Dietrich CF, Mertens JC, Braden B et al. Contrast enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007; 45 (5): 1139-1145
19. Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005; 78: 704-707
20. Frieser M, Schaber S, Peters A et al. Radiofrequency ablation using perfused needle electrodes - study of intermittent and continuous triple needle application ex vivo. Eur Surg Res 2005; 37: 312-316
21. Gaiani S, Celli N, Piscaglia F et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004; 41: 421-426
22. Gebel M, Caselitz M, Bowen-Davies PE, Weber S. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 a (Levovist) for Doppler signal enhancement in the portal vascular system. Ultraschall Med 1998; 19: 148-156
23. Goldberg BB, Hilpert PL, Burns PN et al. Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent. Radiology 1990; 177: 713-717
24. Goldberg BB, Liu JB et al. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med 1993; 12: 463-470
25. Goldberg SN, Solbiati L. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 609-610
26. Gossmann J, Scheuermann EH et al. Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type 1a (von Gierke disease). Transplantation 2001; 72: 343-344
27. Hansler J, Neureiter D, Wasserburger M et al. Percutaneous US-guided radiofrequency ablation with perfused needle applicators: improved survival with the VX2 tumor model in rabbits. Radiology 2004; 230: 169-174
28. Hansler J, Wissniowski TT, Schuppan D et al. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radiofrequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. World J Gastroenterol 2006; 12: 3716-3721
29. Hansler J, Witte A, Strobel D et al. Radio-frequency-ablation (RFA) with wet electrodes in the treatment of primary and secondary liver tumours. Ultraschall Med 2003; 24: 27-33
30. Hohmann J, Skrok J, Puis R, Albrecht T. Charakterisierung fokaler Leberläsionen mit kontrastmittelgestütztem "low MI real time" Ultraschall und SonoVue. Rofo 2003; 175: 835-843
31. Huang-Wei C, Bleuzen A, Bourlier P et al. Differential diagnosis of focal nodular hyperplasia with quantitative parametric analysis in contrast-enhanced sonography. Invest Radiol 2006; 41: 363-368
32. Ignee A, Weiper D, Schuessler G, Teuber G, Faust D, Dietrich CF. Sonographic characterisation of hepatocellular carcinoma at time of diagnosis. Z Gastroenterol 2005; 43: 289-294
33. Lencioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-967
34. Livraghi T, Solbiati L. Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutane-ous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 2003; 97: 3027-3035
35. Moerk H, Ignee A, Schuessler G, Ott M, Dietrich CF. Analysis of neuroendocrine tumor metastases in the liver using contrast enhanced ultrasonography. Scand J Gastroenterol 2007; 42 (5): 652-662
36. Nicolau C, Vilana R et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 2006; 186: 158-167
37. Oldenburg A, Hohmann J, Foert E et al. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 2005; 26: 277-284
38. Plentz RR, Lankisch TO, Basturk M et al. Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy. J Gastroenterol Hepatol 2005; 20: 1134-1136
39. Rickes S, Ocran K et al. Evaluation of Doppler sonographic criteria for the differentiation of hepatocellular carcinomas and regenerative nodules in patients with liver cirrhosis. Ultraschall Med 2002; 23: 83-90
40. Rickes S, Ocran KW, Gerstenhauer G, Neye H, Wermke W. Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound. Dig Dis 2004; 22: 81-86
41. Rickes S, Wermke T, Ocran K, Seitz G, Wermke W. Contrast behaviour of a angiomyolipoma of the liver at echo-enhanced power-Doppler sonography. Ultraschall Med 2002; 23: 338-340
42. Schlottmann K, Klebl F, Zorger N, Feuerbach S, Scholmerich J. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. Z Gastroenterol 2004; 42: 303-310
43. Schuessler G, Fellbaum C, Fauth F et al. The infammatory pseudotumour - an unusual liver tumour. Ultraschall Med 2006; 27: 273-279
44. Schuessler G, Ignee A, Hirche T, Dietrich CF. Signalverstä rkte Lebersonographie - Charakteristika einzelner Lebertumoren und Detektionsmöglichkeiten. Z Gastroenterol 2003; 41: 1167-1176
45. Solbiati L, Ierace T, Tonolini M, Cava L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004; 51 (Suppl): S19-S23
46. Solbiati L, Ierace T, Tonolini M, Osti V, Cava L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001; 13: 149-158
47. Stang A, Keles H et al. Kontrastmittel in der Abdomensonographie: aktueller Stand und Perspektiven. Dtsch Med Wschr 2006; 33: 1813-1818
48. Strobel D, Kleinecke C, Hansler J et al. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas - correlation with histological differentiation. Ultraschall Med 2005; 26: 270-276
49. von Herbay A et al. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 2002; 179: 1273-1279
50. von Herbay A, Vogt C, Willers R, Haussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004; 23: 1557-1568